UK Government launches public consultation on proposed revisions to UK clinical trial legislation
The UK Government, via the Medicines and Healthcare products Regulatory Agency (MHRA), recently announced a call for views on new proposals to improve and strengthen UK clinical trial… read more…
IP asset deals: a blessing or a curse?
In this article for The Patent Lawyer Magazine, Partner Andreas Wietzke discusses Blackberry’s announcement on selling its non-core patent portfolio to Catapult IP Innovations Inc and discusses the… read more…
Global changes to biological sequence listings from 1 July 2022
The big-bang date for implementation of the new WIPO sequence listing standard ST26 is fast approaching All new PCT and national/regional applications filed on or after 1 July 2022 will need to be… read more…
Rise of NFTs and fears over crypto carbon footprint push global blockchain patents to record high
Research carried out by Mathys & Squire, around the rise in global patents related to blockchain technology, has featured in an article published by City AM – click here to read the… read more…
Challenges and opportunities in protecting IP in a deep tech startup
In this article for The Patent Lawyer Magazine, Partners Andrew White and Anna Gregson discuss the importance of protecting IP as an asset, even years before commercial use, in one of the largest… read more…
EPO fee increases from 1 April 2022: What you need to know
The European Patent Office (EPO) has announced it will be increasing official fees by approximately 25% from 1 April 2022 – two years since its last fee increase in April 2020 Full details of the… read more…
Key changes from the Revised Guidelines for Search and Examination at the EPO
Update: 9 March 2022 Having reviewed the final 2022 version which is now in force, there are no substantive changes compared to the preview, which the article is based on With that in mind,… read more…
Mathys & Squire Partners recognised in IAM Strategy 300 Global Leaders 2022
Mathys & Squire Partners Anna Gregson, Dani Kramer and Martin MacLean have been featured in the 2022 edition of IAM Strategy 300 Global Leaders The guide highlights professionals whose… read more…
G1/22 and G2/22: Board of Appeal refers questions on formal priority entitlement to the Enlarged Board of Appeal
In a development that could have a significant impact on how priority is assessed in Europe, EPO Board of Appeal 334 has just referred the following two questions to the Enlarged Board of Appeal… read more…
